CTRI/2023/12/060957
Not Yet Recruiting
Phase 4
Comparision of efficacy and hemodynamic stability between 0.75% ropivacaine and 0.5% levobupivacaine in epidural block for infra umbilical surgeries - Nil
Saveetha medical college and hospital0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Saveetha medical college and hospital
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing infra\-umbilical surgeries
- •Age 18 to 70
- •ASA I \& II patients
Exclusion Criteria
- •Patient refusal
- •Critically ill patients (ASA III \& above)
- •Patients with deformities of the spinal column
- •Evidence of coagulopathy
- •Infection at the site of the proposed epidural needle puncture
- •Patients with mental disturbance or neurological disease
- •Pregnant patients are excluded from the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A study to compare the effectiveness of saddle spinal anesthesia (a technique) and traditional spinal anesthesia in providing anesthesia and maintaining the stability of haemodynamics in patients coming for transurethral resection of prostate surgery (TURP) for prostate enlargementSaddle anesthesiageriatric patients with genito urinary diseaseTURPSpinal anesthesiaTCTR20191122001Azeezia Institute of Medical Sciences & Research, Kollam, Kerala, India90
Completed
N/A
A comparison of the hemodynamic stability between Inhaled general anesthesia and Total Intraveous Anesthesia (TIVA) undergoing coil embolizatioJPRN-UMIN000036951Seoul National University Bundang Hospital2,500
Not Yet Recruiting
Phase 2
A clinical trial to compare the effects of two drugs, ropivacaine and levobupivacaine in patients undergoing cesarean section under spinal anaesthesiaCTRI/2023/09/058070iyaz Abdul Salam
Active, Not Recruiting
N/A
Clinical investigation into efficacy, hemodynamics and tolerability of simvastatin vs placebo in patients with pulmonary arterial hypertension(Shorttitle: SIPHT)Double-blind, randomized, prospective Phase III-b study for 6 months with adjusting doses of simvastatin (40/80 mg daily) or placebo followed by an open-label period with a final dose of simvastatin 80 mg daily for another 6 months - SIPHTModified NYHA class II or III patients with Pulmonary Hypertension (PH), ICD: 416.9MedDRA version: 8.1Level: LLTClassification code 10020787Term: Hypertension pulmonaryEUCTR2005-004863-41-DEDept. of Internal Medicine II, University Hospital Giessen40
Not Yet Recruiting
Phase 2
Comparision of effect of cisatracurium and vecuronium (both muscle relaxant) in a patient undergoing laproscopic appendicectomyCTRI/2019/05/019453Government medical college Bhavnagar